Skip to content

Mechanisms and Emerging Therapeutic Targets in Skeletal Muscle Atrophy

Document Type
Publications · Journal Article
Registered DB
KCI
Journal Ranking
KCI Q3
Journal
생명과학회지36(5) · pp.437 · 2026
Citation
KCI 0
ISSN
1225-9918

Authors

  1. Bakhovuddin AzamovFirst author부산대학교 의과대학 융합의학교실
  2. Song, ParkyongCorresponding author부산대학교

Abstract

Skeletal muscle atrophy-loss of mass and function-emerges with aging, immobilization, critical illness, cancer, and endocrine or neurogenic disorders. Although muscle atrophy is a hallmark of aging and numerous chronic diseases, the molecular drivers underlying its progression remain incompletely understood. Human disuse models demonstrate that early atrophy is driven primarily by declines in myofibrillar protein synthesis, while sustained wasting reflects the combined action of ubiquitin-proteasome and autophagy-lysosome pathways. In parallel, mitochondrial quality control failure caused by impaired mitophagy and endoplasmic reticulum stress integrates inflammatory and hormonal cues to depress protein translation. Simultaneously, single-cell atlases reveal fiber-type and niche-specific vulnerabilities, including denervation signatures and pro-fibrotic stromal states that help explain selective type II fiber loss with aging and disease. Interestingly, emerging evidence further implicates dysregulated lipid metabolism, particularly abnormal cholesterol homeostasis as a key contributor to muscle wasting. Intracellular cholesterol disrupts membrane integrity, impairs mitochondrial function, and activates pro-inflammatory signaling pathways within muscle fibers. Therapeutically, layered programs that pair progressive resistance exercise with protein/leucine distribution restore protein synthesis and muscle function. Furthermore, mitochondrial/UPR(unfolded protein response)-targeted agents (e.g., urolithin A) and anti-inflammatory strategies are expanding therapeutic options in select conditions. The paper offers a concise overview of the biological processes behind skeletal muscle atrophy and explores current therapeutic strategies aimed at mitigating its effects.

Keywords

Autophagymitochondrial dysfunctionmuscle atrophyoxidative stress

Identifiers

KCI
ART003338484